nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—submandibular gland—salivary gland cancer	0.166	0.539	CbGeAlD
Sucralfate—EGF—neck—salivary gland cancer	0.0193	0.0628	CbGeAlD
Sucralfate—FGB—lymphoid tissue—salivary gland cancer	0.0162	0.0526	CbGeAlD
Sucralfate—EGF—parotid gland—salivary gland cancer	0.0157	0.0511	CbGeAlD
Sucralfate—EGF—saliva-secreting gland—salivary gland cancer	0.0151	0.0489	CbGeAlD
Sucralfate—FGA—lymphoid tissue—salivary gland cancer	0.0139	0.045	CbGeAlD
Sucralfate—EGF—connective tissue—salivary gland cancer	0.0138	0.045	CbGeAlD
Sucralfate—EGF—epithelium—salivary gland cancer	0.0131	0.0427	CbGeAlD
Sucralfate—FGG—lymph node—salivary gland cancer	0.0118	0.0385	CbGeAlD
Sucralfate—EGF—lymphoid tissue—salivary gland cancer	0.0101	0.0329	CbGeAlD
Sucralfate—EGF—lymph node—salivary gland cancer	0.00571	0.0186	CbGeAlD
Sucralfate—FGF2—lymph node—salivary gland cancer	0.00504	0.0164	CbGeAlD
Sucralfate—ALB—lymph node—salivary gland cancer	0.00197	0.00641	CbGeAlD
Sucralfate—FGF2—DAP12 interactions—PTEN—salivary gland cancer	0.000257	0.000371	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—PTEN—salivary gland cancer	0.000257	0.000371	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—PTEN—salivary gland cancer	0.000257	0.000371	CbGpPWpGaD
Sucralfate—FGA—Disease—MAP2K2—salivary gland cancer	0.000256	0.00037	CbGpPWpGaD
Sucralfate—EGF—Immune System—FGFR4—salivary gland cancer	0.000256	0.000369	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—PTEN—salivary gland cancer	0.000255	0.000368	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—PIK3CA—salivary gland cancer	0.000254	0.000367	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000254	0.000367	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—PTEN—salivary gland cancer	0.000252	0.000365	CbGpPWpGaD
Sucralfate—EGF—Immune System—FBXW7—salivary gland cancer	0.000252	0.000363	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—PTEN—salivary gland cancer	0.000251	0.000363	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000251	0.000362	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—HRAS—salivary gland cancer	0.00025	0.000362	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—WNT5B—salivary gland cancer	0.000249	0.000359	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.000249	0.000359	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—CREBBP—salivary gland cancer	0.000245	0.000355	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—HRAS—salivary gland cancer	0.000245	0.000354	CbGpPWpGaD
Sucralfate—FGF2—Disease—DTX4—salivary gland cancer	0.000245	0.000353	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000242	0.000349	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL17RD—salivary gland cancer	0.00024	0.000347	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	0.00024	0.000347	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CYLD—salivary gland cancer	0.00024	0.000346	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—PTEN—salivary gland cancer	0.000238	0.000344	CbGpPWpGaD
Sucralfate—EGF—Disease—JAG1—salivary gland cancer	0.000237	0.000342	CbGpPWpGaD
Sucralfate—EGF—Disease—FGFR4—salivary gland cancer	0.000236	0.000341	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—HRAS—salivary gland cancer	0.000235	0.00034	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000235	0.000339	CbGpPWpGaD
Sucralfate—EGF—Disease—FBXW7—salivary gland cancer	0.000232	0.000335	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000231	0.000333	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—FOXO3—salivary gland cancer	0.000231	0.000333	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PRKDC—salivary gland cancer	0.00023	0.000332	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	0.000228	0.000329	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FOXO3—salivary gland cancer	0.000224	0.000324	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGF16—salivary gland cancer	0.000224	0.000323	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—FOXO3—salivary gland cancer	0.000221	0.00032	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CREBBP—salivary gland cancer	0.000221	0.000319	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAML3—salivary gland cancer	0.00022	0.000318	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FOXO3—salivary gland cancer	0.00022	0.000318	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FOXO3—salivary gland cancer	0.00022	0.000318	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGF16—salivary gland cancer	0.000219	0.000316	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	0.000218	0.000314	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MAP2K2—salivary gland cancer	0.000213	0.000308	CbGpPWpGaD
Sucralfate—EGF—Immune System—FOXO3—salivary gland cancer	0.000212	0.000306	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CDH1—salivary gland cancer	0.000211	0.000304	CbGpPWpGaD
Sucralfate—FGF2—Immune System—NUP62—salivary gland cancer	0.00021	0.000303	CbGpPWpGaD
Sucralfate—FGA—Disease—NOTCH1—salivary gland cancer	0.00021	0.000303	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	0.000208	0.000301	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.000208	0.000301	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000205	0.000296	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGF16—salivary gland cancer	0.000202	0.000292	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—PIK3CA—salivary gland cancer	0.000202	0.000292	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—HRAS—salivary gland cancer	0.000201	0.000291	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—PIK3CA—salivary gland cancer	0.000198	0.000286	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—PIK3CA—salivary gland cancer	0.000198	0.000286	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MC3R—salivary gland cancer	0.000196	0.000283	CbGpPWpGaD
Sucralfate—EGF—Disease—FOXO3—salivary gland cancer	0.000196	0.000283	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—salivary gland cancer	0.000196	0.000283	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—PIK3CA—salivary gland cancer	0.000196	0.000283	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—PIK3CA—salivary gland cancer	0.000195	0.000282	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—PIK3CA—salivary gland cancer	0.000195	0.000281	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAML2—salivary gland cancer	0.000194	0.000281	CbGpPWpGaD
Sucralfate—FGF2—Disease—NUP62—salivary gland cancer	0.000194	0.00028	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—PIK3CA—salivary gland cancer	0.000194	0.00028	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—PIK3CA—salivary gland cancer	0.000193	0.000278	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	0.000193	0.000278	CbGpPWpGaD
Sucralfate—FGF2—Disease—VCAN—salivary gland cancer	0.000192	0.000278	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—salivary gland cancer	0.000192	0.000277	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—salivary gland cancer	0.000192	0.000277	CbGpPWpGaD
Sucralfate—FGA—Disease—CREBBP—salivary gland cancer	0.00019	0.000275	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.00019	0.000274	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—HRAS—salivary gland cancer	0.000189	0.000274	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000189	0.000272	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MAP2K2—salivary gland cancer	0.000188	0.000272	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—HRAS—salivary gland cancer	0.000187	0.00027	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—HRAS—salivary gland cancer	0.000183	0.000265	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—HRAS—salivary gland cancer	0.000183	0.000265	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MAP2K2—salivary gland cancer	0.000183	0.000265	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—PIK3CA—salivary gland cancer	0.000181	0.000262	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000181	0.000262	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	0.000181	0.000262	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—HRAS—salivary gland cancer	0.000181	0.000261	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—HRAS—salivary gland cancer	0.000181	0.000261	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—HRAS—salivary gland cancer	0.00018	0.00026	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—PIK3CA—salivary gland cancer	0.00018	0.00026	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MAP2K2—salivary gland cancer	0.000179	0.000259	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MAP2K2—salivary gland cancer	0.000179	0.000259	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—HRAS—salivary gland cancer	0.000179	0.000259	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—HRAS—salivary gland cancer	0.000178	0.000258	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000178	0.000257	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000177	0.000256	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000176	0.000254	CbGpPWpGaD
Sucralfate—FGF2—Disease—MAML2—salivary gland cancer	0.000176	0.000254	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PTEN—salivary gland cancer	0.000175	0.000253	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—NOTCH1—salivary gland cancer	0.000175	0.000252	CbGpPWpGaD
Sucralfate—EGF—Immune System—MAP2K2—salivary gland cancer	0.000173	0.00025	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—DTX4—salivary gland cancer	0.000171	0.000247	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000171	0.000246	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—PIK3CA—salivary gland cancer	0.000168	0.000242	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HRAS—salivary gland cancer	0.000168	0.000242	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000168	0.000242	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000168	0.000242	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—EP300—salivary gland cancer	0.000167	0.000241	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—HRAS—salivary gland cancer	0.000166	0.00024	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—JAG1—salivary gland cancer	0.000166	0.00024	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FGFR4—salivary gland cancer	0.000165	0.000239	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000165	0.000238	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000165	0.000238	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—HRAS—salivary gland cancer	0.000164	0.000237	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FBXW7—salivary gland cancer	0.000163	0.000235	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FGFR4—salivary gland cancer	0.000162	0.000234	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.000161	0.000232	CbGpPWpGaD
Sucralfate—EGF—Disease—MAP2K2—salivary gland cancer	0.00016	0.000231	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000159	0.00023	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FBXW7—salivary gland cancer	0.000159	0.00023	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—CREBBP—salivary gland cancer	0.000158	0.000229	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PTEN—salivary gland cancer	0.000158	0.000228	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—HRAS—salivary gland cancer	0.000155	0.000224	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MYB—salivary gland cancer	0.000154	0.000222	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PTEN—salivary gland cancer	0.000152	0.000219	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EP300—salivary gland cancer	0.00015	0.000217	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOTCH1—salivary gland cancer	0.00015	0.000217	CbGpPWpGaD
Sucralfate—FGF2—Disease—JAG1—salivary gland cancer	0.00015	0.000217	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGFR4—salivary gland cancer	0.000149	0.000216	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000149	0.000215	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOTCH1—salivary gland cancer	0.000147	0.000212	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOTCH1—salivary gland cancer	0.000147	0.000212	CbGpPWpGaD
Sucralfate—FGF2—Disease—FBXW7—salivary gland cancer	0.000147	0.000212	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGF16—salivary gland cancer	0.000142	0.000205	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—salivary gland cancer	0.000141	0.000203	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CREBBP—salivary gland cancer	0.00014	0.000202	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ISYNA1—salivary gland cancer	0.000138	0.0002	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FOXO3—salivary gland cancer	0.000137	0.000198	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CREBBP—salivary gland cancer	0.000136	0.000197	CbGpPWpGaD
Sucralfate—FGA—Disease—PTEN—salivary gland cancer	0.000136	0.000196	CbGpPWpGaD
Sucralfate—FGF2—Immune System—FOXO3—salivary gland cancer	0.000134	0.000194	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CREBBP—salivary gland cancer	0.000133	0.000193	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CREBBP—salivary gland cancer	0.000133	0.000193	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDH1—salivary gland cancer	0.000133	0.000193	CbGpPWpGaD
Sucralfate—EGF—Disease—NOTCH1—salivary gland cancer	0.000131	0.000189	CbGpPWpGaD
Sucralfate—FGA—Disease—EP300—salivary gland cancer	0.00013	0.000187	CbGpPWpGaD
Sucralfate—EGF—Immune System—CREBBP—salivary gland cancer	0.000129	0.000186	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDH1—salivary gland cancer	0.000128	0.000185	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000126	0.000183	CbGpPWpGaD
Sucralfate—FGF2—Disease—FOXO3—salivary gland cancer	0.000124	0.000179	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—PIK3CA—salivary gland cancer	0.000124	0.000179	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—PIK3CA—salivary gland cancer	0.000124	0.000178	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAML2—salivary gland cancer	0.000123	0.000178	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—salivary gland cancer	0.00012	0.000173	CbGpPWpGaD
Sucralfate—EGF—Disease—CREBBP—salivary gland cancer	0.000119	0.000172	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—HRAS—salivary gland cancer	0.000114	0.000165	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—HRAS—salivary gland cancer	0.000114	0.000165	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MARCKS—salivary gland cancer	0.000113	0.000163	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MAP2K2—salivary gland cancer	0.000112	0.000162	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—PIK3CA—salivary gland cancer	0.000111	0.000161	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MAP2K2—salivary gland cancer	0.00011	0.000158	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EP300—salivary gland cancer	0.000108	0.000156	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—PIK3CA—salivary gland cancer	0.000107	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—JAG1—salivary gland cancer	0.000105	0.000152	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PYGB—salivary gland cancer	0.000105	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FGFR4—salivary gland cancer	0.000105	0.000151	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HRAS—salivary gland cancer	0.000103	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FBXW7—salivary gland cancer	0.000103	0.000149	CbGpPWpGaD
Sucralfate—FGF2—Disease—MAP2K2—salivary gland cancer	0.000101	0.000146	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—salivary gland cancer	0.000101	0.000145	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PTEN—salivary gland cancer	9.99e-05	0.000144	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HRAS—salivary gland cancer	9.89e-05	0.000143	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—salivary gland cancer	9.87e-05	0.000142	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—salivary gland cancer	9.87e-05	0.000142	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PTEN—salivary gland cancer	9.72e-05	0.00014	CbGpPWpGaD
Sucralfate—FGA—Disease—PIK3CA—salivary gland cancer	9.59e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PTEN—salivary gland cancer	9.59e-05	0.000139	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EP300—salivary gland cancer	9.52e-05	0.000138	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PTEN—salivary gland cancer	9.52e-05	0.000138	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PTEN—salivary gland cancer	9.52e-05	0.000138	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EP300—salivary gland cancer	9.27e-05	0.000134	CbGpPWpGaD
Sucralfate—EGF—Immune System—PTEN—salivary gland cancer	9.19e-05	0.000133	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOTCH1—salivary gland cancer	9.18e-05	0.000133	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EP300—salivary gland cancer	9.08e-05	0.000131	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EP300—salivary gland cancer	9.08e-05	0.000131	CbGpPWpGaD
Sucralfate—FGA—Disease—HRAS—salivary gland cancer	8.87e-05	0.000128	CbGpPWpGaD
Sucralfate—EGF—Immune System—EP300—salivary gland cancer	8.77e-05	0.000127	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FOXO3—salivary gland cancer	8.68e-05	0.000125	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PHGDH—salivary gland cancer	8.54e-05	0.000123	CbGpPWpGaD
Sucralfate—EGF—Disease—PTEN—salivary gland cancer	8.49e-05	0.000123	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CREBBP—salivary gland cancer	8.32e-05	0.00012	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOTCH1—salivary gland cancer	8.29e-05	0.00012	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ST3GAL4—salivary gland cancer	8.22e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CREBBP—salivary gland cancer	8.15e-05	0.000118	CbGpPWpGaD
Sucralfate—EGF—Disease—EP300—salivary gland cancer	8.09e-05	0.000117	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDH1—salivary gland cancer	8.08e-05	0.000117	CbGpPWpGaD
Sucralfate—FGF2—Disease—CREBBP—salivary gland cancer	7.52e-05	0.000109	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AQP1—salivary gland cancer	7.47e-05	0.000108	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—HRAS—salivary gland cancer	7.38e-05	0.000107	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MAP2K2—salivary gland cancer	7.09e-05	0.000102	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—PIK3CA—salivary gland cancer	7.05e-05	0.000102	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—PIK3CA—salivary gland cancer	6.86e-05	9.9e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—PIK3CA—salivary gland cancer	6.77e-05	9.77e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—PIK3CA—salivary gland cancer	6.72e-05	9.7e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—PIK3CA—salivary gland cancer	6.72e-05	9.7e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—salivary gland cancer	6.63e-05	9.58e-05	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HRAS—salivary gland cancer	6.52e-05	9.42e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—salivary gland cancer	6.5e-05	9.39e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—salivary gland cancer	6.5e-05	9.39e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—PIK3CA—salivary gland cancer	6.48e-05	9.37e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—HRAS—salivary gland cancer	6.34e-05	9.16e-05	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HRAS—salivary gland cancer	6.26e-05	9.04e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—HRAS—salivary gland cancer	6.21e-05	8.98e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—HRAS—salivary gland cancer	6.21e-05	8.98e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—salivary gland cancer	6.16e-05	8.89e-05	CbGpPWpGaD
Sucralfate—EGF—Immune System—HRAS—salivary gland cancer	6e-05	8.67e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—PIK3CA—salivary gland cancer	5.99e-05	8.65e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PTEN—salivary gland cancer	5.94e-05	8.58e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NUP62—salivary gland cancer	5.92e-05	8.55e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—VCAN—salivary gland cancer	5.88e-05	8.49e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PTEN—salivary gland cancer	5.82e-05	8.4e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOTCH1—salivary gland cancer	5.81e-05	8.39e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EP300—salivary gland cancer	5.67e-05	8.19e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CREBBP—salivary gland cancer	5.66e-05	8.18e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EP300—salivary gland cancer	5.55e-05	8.01e-05	CbGpPWpGaD
Sucralfate—EGF—Disease—HRAS—salivary gland cancer	5.54e-05	8e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—salivary gland cancer	5.54e-05	8e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTEN—salivary gland cancer	5.37e-05	7.76e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CREBBP—salivary gland cancer	5.27e-05	7.61e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	5.16e-05	7.45e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—EP300—salivary gland cancer	5.12e-05	7.4e-05	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	4.9e-05	7.08e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—PIK3CA—salivary gland cancer	4.19e-05	6.06e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—PIK3CA—salivary gland cancer	4.1e-05	5.93e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—salivary gland cancer	4.06e-05	5.86e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—salivary gland cancer	3.9e-05	5.63e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HRAS—salivary gland cancer	3.88e-05	5.6e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—EP300—salivary gland cancer	3.86e-05	5.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HRAS—salivary gland cancer	3.8e-05	5.48e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PIK3CA—salivary gland cancer	3.79e-05	5.47e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTEN—salivary gland cancer	3.76e-05	5.43e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	3.68e-05	5.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EP300—salivary gland cancer	3.59e-05	5.18e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	3.51e-05	5.07e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—HRAS—salivary gland cancer	3.51e-05	5.06e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—PIK3CA—salivary gland cancer	2.85e-05	4.12e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—salivary gland cancer	2.76e-05	3.99e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PIK3CA—salivary gland cancer	2.65e-05	3.83e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—HRAS—salivary gland cancer	2.64e-05	3.81e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	2.6e-05	3.75e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—salivary gland cancer	2.57e-05	3.71e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HRAS—salivary gland cancer	2.45e-05	3.55e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CREBBP—salivary gland cancer	2.3e-05	3.32e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTEN—salivary gland cancer	1.64e-05	2.37e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—EP300—salivary gland cancer	1.56e-05	2.26e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PIK3CA—salivary gland cancer	1.16e-05	1.67e-05	CbGpPWpGaD
